McKesson Corporation (LON:0JZU)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	65,999	65,281	55,857	39,411	34,886	22,534
Market Cap Growth	16.87%	16.87%	41.73%	12.97%	54.81%	17.13%
Enterprise Value	67,587	72,277	60,631	44,111	39,322	28,072
Last Close Price	525.99	518.31	423.41	286.71	230.23	139.18
PE Ratio	25.88	25.60	23.50	13.70	41.17	-
PS Ratio	0.24	0.24	0.23	0.18	0.17	0.13
PB Ratio	-50.34	-49.79	-44.12	-32.72	-25.59	21.47
P/FCF Ratio	15.37	15.20	18.17	10.22	11.33	7.59
P/OCF Ratio	14.01	13.86	16.35	9.45	10.34	6.84
EV/Sales Ratio	0.25	0.26	0.25	0.20	0.20	0.16
EV/EBITDA Ratio	15.04	17.24	14.99	11.32	10.79	9.80
EV/EBIT Ratio	18.18	19.00	16.74	12.65	12.46	12.18
EV/FCF Ratio	15.74	16.83	19.72	11.44	12.78	9.45
Debt / Equity Ratio	-4.38	-4.38	-4.64	-4.91	-4.25	6.61
Debt / EBITDA Ratio	1.25	1.25	1.32	1.37	1.42	2.11
Debt / FCF Ratio	1.34	1.34	1.91	1.53	1.88	2.34
Asset Turnover	5.04	5.04	4.76	4.41	4.11	3.77
Inventory Turnover	15.69	15.69	14.52	13.78	13.22	12.58
Quick Ratio	0.51	0.51	0.50	0.50	0.46	0.58
Current Ratio	0.90	0.90	0.92	0.92	0.95	1.03
Return on Equity (ROE)	-	-	-	-	-	-106.39%
Return on Assets (ROA)	4.31%	4.31%	4.41%	4.29%	4.04%	3.14%
Return on Capital (ROIC)	53.21%	53.21%	49.08%	46.31%	30.81%	14.63%
Return on Capital Employed (ROCE)	36.30%	36.30%	30.30%	30.00%	28.00%	15.20%
Earnings Yield	3.86%	3.91%	4.25%	7.30%	2.43%	-14.62%
FCF Yield	6.51%	6.58%	5.50%	9.78%	8.82%	13.18%
Dividend Yield	0.31%	0.41%	0.45%	0.59%	0.60%	0.87%
Payout Ratio	10.47%	10.47%	10.46%	8.20%	24.87%	-
Buyback Yield / Dilution	4.47%	4.47%	5.70%	7.72%	4.05%	11.56%
Total Shareholder Return	4.79%	4.88%	6.14%	8.31%	4.65%	12.44%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.